Arthrosurface’s Ovomotion shoulder arthroplasty system received 510(k) clearance from the FDA for marketing and is cleared for use with the novel Arthrosurface Inlay Glenoid System.

It is designed for patients with painful or severely disabled shoulder joints caused by arthritis, traumatic events or avascular necrosis.

The stemless total shoulder system enables surgeons to minimize bone removal.